KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Equity (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Return on Equity for 8 consecutive years, with 0.05% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 9.0% to 0.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05% through Dec 2025, down 9.0% year-over-year, with the annual reading at 0.05% for FY2025, 10.0% down from the prior year.
  • Return on Equity hit 0.05% in Q4 2025 for Castle Biosciences, down from 0.03% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.04% in Q4 2024 to a low of 0.23% in Q2 2023.
  • Historically, Return on Equity has averaged 0.09% across 5 years, with a median of 0.07% in 2021.
  • Biggest five-year swings in Return on Equity: decreased -12bps in 2021 and later rose 23bps in 2024.
  • Year by year, Return on Equity stood at 0.09% in 2021, then crashed by -78bps to 0.17% in 2022, then increased by 11bps to 0.15% in 2023, then soared by 128bps to 0.04% in 2024, then crashed by -226bps to 0.05% in 2025.
  • Business Quant data shows Return on Equity for CSTL at 0.05% in Q4 2025, 0.03% in Q3 2025, and 0.02% in Q2 2025.